Source link : https://newshealth.biz/health-news/incretin-based-meds-may-modestly-raise-biliary-risk-in-t2d/
Patients with T2D taking incretin-based drugs do not face an increased risk for pancreatitis but have a modestly higher risk for biliary events than those on SGLT2 inhibitors. Medscape Medical News Source link : https://www.medscape.com/viewarticle/incretin-based-meds-may-modestly-raise-biliary-risk-t2d-2025a1000ytp?src=rss Author : Publish date : 2025-12-11 19:11:00 Copyright for syndicated content belongs to the linked Source.
The post Incretin-Based Meds May Modestly Raise Biliary Risk in T2D first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-11 19:11:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8